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Summary
Background Control of cervical cancer in developing countries has been hampered by a failure to achieve high 
screening uptake. HPV DNA self-collection could increase screening coverage, but implementation of this technology 
is diﬃ  cult in countries of middle and low income. We investigated whether oﬀ ering HPV DNA self-collection during 
routine home visits by community health workers could increase cervical screening.
Methods We did a population-based cluster-randomised trial in the province of Jujuy, Argentina, between July 1, 2012, 
and Dec 31, 2012. Community health workers were eligible for the study if they scored highly on a performance score, 
and women aged 30 years or older were eligible for enrolment by the community health worker. 200 community 
health workers were randomly allocated in a 1:1 ratio to either the intervention group (oﬀ ered women the chance to 
self-collect a sample for cervical screening during a home visit) or the control group (advised women to attend a 
health clinic for cervical screening). The primary outcome was screening uptake, measured as the proportion of 
women having any HPV screening test within 6 months of the community health worker visit. Analysis was by 
intention to treat. This trial is registered with ClinicalTrials.gov, number NCT02095561.
Findings 100 community health workers were randomly allocated to the intervention group and 100 were assigned to 
the control group; nine did not take part. 191 participating community health workers (94 in the intervention group 
and 97 in the control group) initially contacted 7650 women; of 3632 women contacted by community health workers 
in the intervention group, 3049 agreed to participate; of 4018 women contacted by community health workers in the 
control group, 2964 agreed to participate. 2618 (86%) of 3049 women in the intervention group had any HPV test 
within 6 months of the community health worker visit, compared with 599 (20%) of 2964 in the control group 
(risk ratio 4·02, 95% CI 3·44–4·71).
Interpretation Oﬀ ering self-collection of samples for HPV testing by community health workers during home visits 
resulted in a four-fold increase in screening uptake, showing that this strategy is eﬀ ective to improve cervical screening 
coverage. This intervention reduces women’s barriers to screening and results in a substantial and rapid increase in 
coverage. Our ﬁ ndings suggest that HPV testing could be extended throughout Argentina and in other countries to 
increase cervical screening coverage.
Funding Instituto Nacional del Cáncer (Argentina).
Copyright ©Arrossi et al. Open Access article distributed under the terms of CC BY-NC-ND.
Introduction
A key factor that has hampered control of cervical cancer 
in developing countries is failure to achieve high 
screening uptake; recruitment through opportu nistic 
screening and promotion has been insuﬃ  cient, 
particularly among women from poor populations.1,2 In 
Argentina, more than 60% of women with low education 
have not had a Papanicolaou (Pap) test in the past 2 years.3
In recent years, testing for human papillomavirus 
(HPV) DNA has changed the scenario. This new 
technology is more eﬀ ective than cytology for the 
detection of precursors of cervical cancer and oﬀ ers the 
possibility of reducing screening frequency.4 Through 
self-collection, HPV DNA testing could reduce barriers 
to screening and increase coverage.5 The method is 
highly accurate6,7 and is acceptable for women in diﬀ erent 
countries.8–10 Nonetheless, translation of this acceptability 
into packages of care for public health systems remains a 
major challenge. Eﬀ ectiveness of HPV self-collection 
relies on several programmatic issues, including delivery 
and transport of sample collection kits and referral of 
women.11 Delivering sample containers and returning 
samples via the postal system has been proposed,7,12,13 but 
this strategy is not feasible in most developing countries.
To address complex health problems such as low 
coverage, technological changes need to be integrated 
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with social innovations to ensure that the new technology 
is actually implemented among the population that 
needs it most.14 Therefore, to achieve the highest eﬀ ect, 
self-collection must be implemented with social develop-
ments that allow the innovation to be scaled in the 
speciﬁ c contexts of countries of middle-to-low income.
The increasing role of community health workers to 
address the challenge of delivering services to under-
served populations through education, outreach, and 
counselling is now recognised.15–17 However, commu nity 
health work has been mainly oriented to maternal and 
child care and control of communicable diseases.17 The 
eﬀ ectiveness of home promotion activities by community 
health workers to increase demand for cytological 
screening18–22 has been limited, because those outreach 
eﬀ orts cannot translate into screening owing to access 
barriers to health care.
We postulated that a real diﬀ erence could be made in 
control of cervical cancer by combining a new technology 
(HPV DNA testing) with a social innovation (incorporation 
of self-collection into routine home visits by community 
health workers). To evaluate this combination, we did the 
self-collection modality study (known as the EMA study), 
a population-based cluster-randomised trial set in Jujuy, 
an Argentinean province with one of the highest rates of 
mortality from cervical cancer nationally.23 In Jujuy, 
primary HPV testing was introduced in 201124 and, despite 
important eﬀ orts of the province to promote screening, 
estimated coverage is around 50%.3
Methods
Setting and participants
Jujuy is located in northwest Argentina; 85% of the 
population live in urban areas. The public health system 
includes a main hospital and 270 primary health-care 
centres. Since 2012, HPV DNA testing has been the 
primary screening test for cervical cancer, available for all 
women aged 30 years or older who attend public health 
centres. The primary health-care system employs about 
700 paid full-time community health workers who visit 
about 110 000 households twice a year for health-related 
tasks such as immunisation and promotion of maternal 
and child health. The performance of community health 
workers is evaluated annually and scored as good or 
suboptimum by supervisors in the primary health-care 
system, according to achievement of established goals 
(eg, the number of home visits).
We regarded community health workers as clusters in 
the study and judged them eligible if they were working in 
Jujuy’s public health system in July, 2012, and had received 
a good performance score in 2011. Community health 
workers in rural areas of Jujuy are assigned a mean of 
52 women (aged ≥30 years), whereas those working in 
urban areas have on average 155 women assigned to them. 
A woman was eligible for the study if she was 30 years 
or older and living in a household visited by community 
health workers. Women at home during the routine visit 
were invited to participate but excluded if they had had a 
previous HPV DNA test, a hysterectomy, or treatment for 
premalignant or malignant disease, were pregnant, or 
had a mental disability.
All women gave written informed consent. The 
bioethics review committee of Jujuy’s Ministry of Health 
approved the study.
Randomisation and masking
Of 698 community health workers working in the Jujuy 
primary health-care system, 488 were eligible and were 
stratiﬁ ed into four groups according to sex and setting 
(either urban or rural). We selected at random (using a 
computer-generated random number list) a stratiﬁ ed 
sample of 200 community health workers, with propor-
tional allocation to strata. Within strata, we assigned 
community health workers at random, in a 1:1 ratio, to 
either the intervention group or control group. We also 
used a computer-generated random number list for the 
intervention allocation. All selected community health 
workers were informed about the study by the head of the 
primary health-care system. Masking of intervention and 
outcome assessments was not feasible.
Procedures
We provided training for all community health workers 
on cervical cancer prevention and HPV DNA testing, and 
informed them about the EMA study objectives and 
protocol. For community health workers allocated to the 
intervention group, we also included a training module 
on communication strategies to instruct women on self-
collection. In total, for all community health workers, 
we held two 1-day workshops, which were led by EMA 
team members.
Community health workers from both groups 
identiﬁ ed eligible women during their routine home 
visits, explained the aims of the study, and obtained 
written informed consent; they also talked to women 
about cervical cancer prevention and HPV DNA testing. 
Community health workers allocated to the control 
group advised women to seek cervical screening at 
health centres; women were free to go to any one of 
270 provincial health centres. Community health workers 
assigned to the intervention group oﬀ ered women self-
collection and provided education and a leaﬂ et on how to 
do the procedure. They asked women if they accepted 
self-collection and recorded the answer on a question-
naire. Women accepting self-collection could deliver the 
sample immediately or the day after, in which case 
community health workers revisited them. Women who 
did not choose self-collection were encouraged to get 
screened at health centres. Table 1 shows details of the 
intervention components.
Women self-collected samples with a cervical sampler 
kit (Qiagen, Gaithersburg, MD, USA), which comprised a 
cervical brush, specimen container, and transport 
medium.  Community health workers received these kits 
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at the training workshops; if they needed additional units 
they could obtain them from health centres or the 
provincial programme headquarters. During the visit, 
community health workers instructed women how to 
insert the head of the brush into the vagina and place it 
into the container. They labelled the specimen container 
with the woman’s name and her unique national 
identiﬁ er number. Community health workers trans-
ported specimens at room temperature to health centres; 
from here they were sent to the provincial HPV laboratory, 
usually once a week, by the health centre or second-level 
hospital. Specimens arriving at the laboratory more than 
14 days after collection were not processed. At the 
laboratory, technicians analysed the HPV DNA status for 
13 high-risk HPV types using hybrid-capture 2, following 
the manufacturer’s instructions.
According to national guidelines,25 cytological samples 
are taken at the same time that clinician-collected HPV 
testing is done, but the sample is only read if the woman 
is HPV-positive; women with samples that include 
atypical cells of undetermined signiﬁ cance or more 
(ASCUS+) are referred for colposcopy. We referred 
women who provided a self-collected sample and were 
HPV-positive for colposcopy and biopsy (if needed), 
which avoided an additional visit for cytological triage. 
Women from both the intervention and control groups 
went to health centres to receive their test results. 
Colposcopies were done by colposcopists from the public 
health system who received speciﬁ c training on the 
project protocol and also a refresher course to unify 
colposcopic classiﬁ cation and diagnostic criteria. 
On average, distance to travel to colposcopy units was 
19 km (SD 27, range 1–211). Biopsy ﬁ ndings were 
reported according to cervical intraepithelial neoplasia 
(CIN) terminology. Identiﬁ ed cases of CIN2+ were 
treated according to standard protocols (LEEP for CIN).25 
We advised HPV-negative women to repeat screening 
within 3 years.
A national screening information system (SITAM) 
records data on screening tests and diagnostic procedures 
done within the public health system. SITAM was linked 
to the study database to identify women with HPV tests 
and other procedures and to extract information about 
Pap testing in the past 4 years. We also obtained 
information on patients’ education and health insurance 
from the primary health care system database and from 
the questionnaire that was administered by community 
health workers during enrolment of women. For the 
intervention group, we also included a question about 
self-sampling acceptability.
Outcome measures
The primary outcome was screening uptake, deﬁ ned at 
the individual participant level as the proportion of 
women with any HPV test (self-collected or clinician-
collected) registered in SITAM within 6 months after the 
community health worker visit. We also analysed 
screening uptake at community health worker (cluster) 
level, which we deﬁ ned as the proportion of women with 
any HPV test per community health worker. We did the 
primary analysis by intention to treat.
We measured several secondary outcomes at the 
individual participant level. First, we analysed reported 
acceptability—ie, the proportion of women from the 
intervention group who, according to the questionnaire, 
accepted self-collection, independently of whether or not 
they were indeed tested. Second, we assessed HPV 
positivity. Finally, we investigated detection of CIN2+ 
disease, deﬁ ned as the proportion of women with 
histologically conﬁ rmed CIN2+ disease during the 
follow-up period (until Dec 31, 2013) out of the total 
number of women tested with each type of test (self-
collected or clinician-collected). Additionally, we reported 
the number of CIN2+ cases per 1000 women in each 
study group.
Statistical analysis
We designed the EMA study to have more than 90% 
power to detect a 10% increase in screening uptake for 
the intervention group, compared with a 50% screening 
uptake in the control group (two-sided α of 0·05). Based 
on primary health-care system records for the years 
2011–12, we estimated that community health workers 
would enrol an average of 30 women in 6 months. 
We included correlation induced by community health 
workers in our sample size calculations, assuming an 
intraclass correlation coeﬃ  cient of 0·10, which resulted 
in a sample of 100 community health workers per study 
group and a total of about 6000 women enrolled.
To account for the cluster design, we used two 
analytical strategies. First, at the level of the individual 
participant, we assessed the intervention eﬀ ect using 
generalised linear models, log link, and Poisson 
distribution, taking into account data clustering.26 
We report risk ratios and 95% CIs. To analyse eﬀ ect 
modiﬁ cation, we ﬁ tted a model including Pap testing in 
the past 4 years and Pap study group interaction. 
We ﬁ tted the same generalised linear model described 
above to evaluate the association between self-collection 
(self-collected tests registered in SITAM) and community 
health worker characteristics (sex, urban or rural work 
Intervention 
cluster
Control 
cluster
Promotion of HPV testing at health centres ü ü
HPV test kits included among community 
health workers’ home visit materials
ü x
Education materials about self-collection 
included among home visit materials
ü x
Oﬀ ering of self-collection ü x
Delivering of samples to health centres, to be 
transported to the HPV laboratory
ü x
Table 1: Intervention components
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setting), after adjusting for women’s age, health 
insurance, education level, and a Pap test in the past 
4 years. Second, we estimated screening uptake using 
the community health worker as the unit of analysis—ie, 
deﬁ ning the proportion of screened women per 
community health worker—and we compared study 
groups with the Kruskal-Wallis test. To assess potential 
bias attributable to the randomised community health 
workers who did not participate, we reanalysed data 
assuming a nil proportion of women tested for these 
community health workers. We compared detection of 
CIN2+ disease and CIN2+ cases per 1000 women with 
Fisher’s exact test. We used SAS version 9.2 for all 
analyses. This trial is registered with ClinicalTrials.gov, 
number NCT02095561.
Role of the funding source
Local health personnel participated actively in design and 
planning of the study. The funder had no role in study 
design, data collection, data analysis, data interpretation, 
or writing of the report. The corresponding author had 
full access to all data in the study and had ﬁ nal 
responsibility for the decision to submit for publication.
Results
Between July 1, 2012, and Dec 31, 2012, 200 community 
health workers were enrolled to the study and randomly 
allocated in a 1:1 ratio to either the intervention group 
(n=100) or the control group (n=100; ﬁ gure 1). Of these, 
nine did not take part (three men [33%]; four people from 
rural areas [44%]), for reasons including illness and 
Figure 1: Trial proﬁ le
CHW=community health worker. 
200 CHWs randomised (1:1) to 
 study group
191 participating CHWs (clusters)
476 excluded
107 refused
903 excluded
94 CHWs assigned to intervention  group 97 CHWs assigned to control group
3632 women visited 4018 women visited
337 without
 tests
96 with
 clinician-
 collected
 tests
151 refused
3156 eligible women
433 women refused self-collection 
 tests
2616 women accepted 
 self-collection tests
599 women clinician-collected 
 tests
2365 women without tests
3115 eligible women
3049 in intervention group (CHWs oﬀered
 self-collection)
2964 in control group (CHWs promoted
 clinician-collected tests)
9 not able to participate
97 without
 self-
 collected
 tests
2519 with
 self-
 collected
 tests
33 sample
 not
 processed
64 changed
 their 
 mind
3 with
 clinician-
 collected
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61 without
 tests
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maternity leave. Therefore, 94 community health workers 
were in the intervention group and 97 were in the control 
group. Community health workers who agreed to 
participate were predominantly women (146, 76%) and 
worked in urban settings (133, 70%; table 2). No diﬀ erence 
was noted in sex (p=0·45) or setting (p=0·15) between 
participating community health workers and those who 
declined to participate. 
The 191 participating community health workers 
contacted 7650 women in total. Of 3632 women initially 
contacted by community health workers allocated to the 
intervention group, 3156 were eligible and 3049 (97%) 
agreed to participate. Of 4018 women initially contacted 
by community health workers assigned to the control 
group, 3115 were eligible and 2964 (95%) agreed to 
participate. When compared with enrolled women, 
those who did not participate (n=258) were older 
(age 30–39 years, 19%; 40–49 years, 26%; 50–64 years, 
31%; and ≥65 years, 23%; p<0·0001). The mean number 
of women enrolled by community health workers 
allocated to the intervention group was 32·4 (SD 26·8, 
range 1–107), and for those assigned to the control group, 
the mean number of women enrolled was 30·6 (25·2, 
2–99). Of all enrolled women, 4286 (71%) had not had a 
Pap test in the past 4 years (table 2).
2616 (86%) of 3049 women in the intervention group 
accepted self-collection when it was oﬀ ered to them; of 
these women, 97 were not tested (ﬁ gure 1): 64 chose to 
deliver the sample the day after but changed their mind, 
and 33 collected the specimen but it was not processed 
because of logistical problems. 99 women from the 
intervention group had clinician-collected HPV tests.
2618 (86%) of 3049 women in the intervention group 
had any HPV test within 6 months of the community 
health worker visit, compared with 599 (20%) of 2964 in 
the control group (risk ratio 4·02, 95% CI 3·44–4·71; 
table 3). 2519 (96%) of 2618 tests in the intervention 
group were self-collected samples. Having a Pap test in 
the past 4 years was an eﬀ ect modiﬁ er (p<0·0001); the 
eﬀ ect of the intervention was stronger among women 
who had not had a Pap test in the past 4 years (risk ratio 
4·98, 95% CI 4·12–6·02) than among women who had 
had a Pap test (2·76, 2·39–3·20). Having a self-collected 
test was not associated with the sex of the community 
health worker or with an urban or rural work setting 
(table 4).
Data were also analysed at cluster level, expressing 
screening uptake as the proportion of women tested per 
community health worker; ﬁ gure 2 summarises the 
results attained by community health workers. Compared 
with workers assigned to the control group, a remarkable 
increase was noted in the proportion of women having 
any HPV test per community health worker allocated to 
the intervention group (p<0·0001). Furthermore, large 
variability was recorded in community health worker 
outcomes. For example, in the intervention group, more 
than 50% of community health workers were very 
successful, with more than 91% of women having 
Total 
population
Intervention 
group
Control 
group
Community health workers
Total (n) 191 94 97
Sex
Men 45 (24%) 21 (22%) 24 (25%)
Women 146 (76%) 73 (78%) 73 (75%)
Area*
Urban 133 (70%) 67 (72%) 66 (68%)
Rural 57 (30%) 26 (28%) 31 (32%)
Women
Total (n) 6013 3049 2964
Age (years)
30–39 2536 (42%) 1294 (42%) 1242 (42%)
40–49 1582 (26%) 784 (26%) 798 (27%)
50–64 1509 (25%) 762 (25%) 747 (25%)
≥65 386 (6%) 209 (7%) 177 (6%)
Education†
Never went to school, 
or primary education 
incomplete
960 (17%) 488 (17%) 472 (17%)
Primary complete but 
secondary incomplete
2664 (48%) 1373 (48%) 1291 (47%)
Secondary complete 1193 (21%) 600 (21%) 593 (22%)
Tertiary (incomplete or 
complete)
782 (14%) 401 (14%) 381 (14%)
Health insurance‡
Public system 3027 (53%) 1472 (51%) 1555 (56%)
Private or social 
security
2650 (47%) 1409 (49%) 1241 (44%)
Pap test in past 4 years
Yes 1727 (29%) 889 (29%) 838 (28%)
No 4286 (71%) 2160 (71%) 2126 (72%)
Pap=Papanicolaou. *Data missing for one community health worker. †Data 
missing for 414 women. ‡Data missing for 336 women.
Table 2: Characteristics of community health workers and women
Women tested/
total women (%)
Risk ratio 
(95% CI)
p
All women*
Control group 599/2964 (20%) ·· ··
Intervention group 2618/3049 (86%) 4·02 (3·44–4·71) <0·0001
Women with no Pap test in past 4 years
Control group 336/2126 (16%) ·· ··
Intervention group 1874/2160 (87%) 4·98 (4·12–6·02) <0·0001
Women with a Pap test in past 4 years
Control group 336/838 (40%) ·· ··
Intervention group 771/889 (87%) 2·76 (2·39–3·20) <0·0001
Risk ratios, 95% CIs, and p values based on a modiﬁ ed Poisson generalised linear 
model, taking into account the clustering induced by community health workers. 
Pap=Papanicolaou. *Intracluster correlation coeﬃ  cient for the primary outcome, 
0·098.
Table 3: Primary outcome of screening uptake by women
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cervical screening; however, 25% of community health 
workers had a comparatively low performance, with less 
than 78% of women having any HPV test. Including all 
randomly allocated community health workers, and 
imputing zero women with tests to non-participant 
community health workers, produced comparable 
results.
Follow-up ended on Dec 31, 2013, 12 months after the 
last woman was enrolled. Median follow-up was 84 days 
(IQR 45–142). Of 2519 women in the intervention group 
with a self-collected specimen and an HPV test result, 
298 (12%) tested positive for HPV. Of these women, 
232 (78%) attended for colposcopy during the study 
follow-up period (in 202 [87%] women, colposcopy was 
done jointly with or after a Pap test): 179 had normal 
ﬁ ndings and 53 had an abnormal result (ﬁ gure 3). 
For these 232 women, the average time from receiving 
their HPV test result to having colposcopy was 
100 days (SD 67, range 6–305). Another 33 women had 
colpo scopies done in the private sector, which were not 
included in the CIN2+ calculation. 48 biopsy procedures 
were done (ﬁ ve women with abnormal colposcopy had 
no biopsy results). 
CIN2+ disease was detected in 29 (1·15%) of 2519 women 
in the intervention group who provided a self-collected 
sample and had a test result. Of these 29 women, 21 (72%) 
had been treated by Dec 31, 2013 (mean time from 
diagnosis to treatment was 91 days, SD 76, range 11–272). 
When results of cytology from this group were used to 
recalculate the number of cases of CIN2+ detected after 
cytological triage, as was done in the control group, 
24 CIN2+ lesions were detected by self-collection.
Of 698 women with clinician-collected tests (99 from 
the intervention group and 599 controls), 81 (12%) tested 
positive for HPV; 32 of these women had ASCUS+. 
Women who had a clinician-collected HPV test and were 
positive for HPV were referred for colposcopy only if they 
had abnormal ﬁ ndings on cytology. 23 (72%) of 
32  women with ASCUS+ had colposcopy during the 
study follow-up period: eight had normal results and 
15 had abnormal ﬁ ndings on biopsy. For these patients, 
the mean time from receiving their HPV test result to 
having colposcopy was 68 days (SD 43, range 7–144). 
Of the 698 women with clinician-collected tests, 
nine (1·29%) had CIN2+ disease detected. Six (67%) 
women had been treated by Dec 31, 2013 (mean time 
from diagnosis to treatment was 80 days, SD 92, range 
10–242). Diﬀ erences in HPV positivity and CIN2+ 
detection between methods (self-collection and clinician-
collection) were not signiﬁ cant. In total, 31 women with 
CIN2+ disease were detected in the intervention group 
(29 with self-collected tests and two with clinician-
collected tests) compared with seven in the control group 
(10·2 CIN2-positive cases per 1000 participant women vs 
2·4 per 1000 controls; p=0·0002). 
Discussion
The main objective of the EMA study was to assess the 
eﬀ ect on cervical cancer screening uptake of oﬀ ering self-
collection of samples for HPV testing by community 
health workers during home visits. This intervention 
resulted in a four-fold increase in screening uptake, 
showing that it is an eﬀ ective strategy to improve cervical 
screening coverage. Furthermore, oﬀ ering women self-
collection resulted in detection of almost ﬁ ve times more 
cases of CIN2+ disease than usual. A cluster design, with 
the community health worker as the unit of randomi-
sation, was chosen to minimise contamination and make 
the study logistically feasible. As far as we know, the 
EMA study is the ﬁ rst of its kind to be done in a 
programmatic real-world context in a low-resource 
region. The study was implemented in Jujuy, the ﬁ rst 
Argentinean province to introduce primary HPV testing 
for cervical cancer screening.
Several randomised trials in developed countries have 
compared the eﬀ ect of sending self-sampler kits via the 
Self-collected 
tests (n=2519)*
Risk ratio 
(95% CI)
p
Sex of community health worker
Men 286 (77%) 1·09 (0·93–1·27) 0·279
Women (reference) 2233 (83%) ·· ··
Area†
Urban 2101 (84%) 0·95 (0·84–1·06) 0·351
Rural (reference) 417 (75%) ·· ··
Risk ratios, 95% CIs, and p values are based on a modiﬁ ed Poisson generalised 
linear model including sex of the community health worker, area, woman’s age, 
education level, health insurance, and Papanicolaou (Pap) test in the past 4 years 
as ﬁ xed eﬀ ect and taking into account the clustering induced by community 
health workers. 2798 women in the intervention arm had complete data. 
*92 community health workers had at least one woman provide a self-collected 
test. †Data missing for one community health worker.
Table 4: Association between characteristics of community health 
workers and women with self-collected tests
Figure 2: Screening uptake at cluster level
94 CHWs were in the intervention group; 97 CHWs were in the control group. 
Control versus intervention, p<0·0001. The lower and upper end of the green 
box represent the ﬁ rst and third quartile, respectively; the solid line represents 
the median; + represents the mean; vertical lines show the range of the Tukey 
boxplot threshold; outliers are denoted with asterisks. 
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postal system instead of sending a letter inviting the 
woman for cytology,5,8,12,13,27 with low-to-moderate eﬀ ects 
reported. In one study,8 a 40% increase in adherence was 
seen in some locations. In developing countries, this 
strategy is not feasible because of limitations of the postal 
system and few reliable addresses. Additionally, the 
absence of face-to-face explanation of self-collection and 
how to do it might strongly limit acceptability and uptake, 
particularly among women of low education.
Findings of non-randomised studies from developing 
countries showed the high potential eﬀ ect of self-
collection oﬀ ered through home visits to increase cervical 
cancer screening uptake.9,28 In a study from Chile,9 
in which two community health workers received a small 
economic incentive per visit, 86·5% screening uptake 
was reported. In our study, oﬀ ering self-sampling was an 
additional task in community health worker activities, 
with no incentive provided. In fact, key project 
components (sample transportation and processing, 
result communication, and referral for diagnosis or 
treatment) were done in a programmatic real-world 
setting and were subject to staﬀ  constraints and 
competing demands of public health care. Our study 
reﬂ ects what can be realistically achieved with self-
collection delivered by community health workers to 
increase screening uptake.
With our study design we were able to distinguish the 
eﬀ ects of the community health worker from the 
intervention, because we compared women receiving the 
intervention with a control group who were only advised 
by the community health worker to attend a clinic for 
clinician-collected HPV testing. Door-to-door canvassing 
is believed to be a moderately eﬀ ective way of recruiting 
women for cancer control programmes,20,29 depending on 
intensity and uptake deﬁ nition. In a study among Chinese 
women in the USA, signiﬁ cant diﬀ erences were noted 
between intervention and control groups with respect to 
planned, but not actual, screening,30 suggesting that 
community health workers succeeded in creating 
awareness but not in reducing barriers. In our study, the 
Figure 3: Follow-up of women positive for high-risk HPV
CHW=community health worker. HPV=human papillomavirus. *33 tested by private service, ﬁ ve negative Pap test, three moved, four refused or could not have 
treatment, one died, 20 no data available. †One moved, one no data available. ‡One moved, one refused treatment, ﬁ ve no data available. 
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intervention resulted in 85·9% of women having an HPV 
test, compared with 20·2% in the control group, and this 
higher proportion was mainly attributable to self-
collection. In Jujuy, HPV testing has been established as 
the primary screening test for cervical cancer, which is 
oﬀ ered free of charge in all public health centres. Our 
study ﬁ ndings suggest that, despite the test’s availability, 
women in the control group faced barriers to get tested. 
These barriers would be reduced by the oﬀ er of HPV self-
collection at home. The eﬀ ect of the intervention was 
strongest in the subgroup of women who had not had a 
Pap test in the past 4 years, suggesting that whereas 
self-collection was eﬀ ective to change behaviour in 
screening under-users, promotion of testing at health 
centres was more eﬀ ective among women who usually get 
screened. These results show that synergy between 
two innovations—HPV self-collection and reorganisation 
of roles of community health workers—can result in a 
substantial increase in cervical screening uptake. 
Moreover, cervical cancer prevention can be integrated 
into the role of the community health worker as part of 
primary health-care system activities. However, incor-
porating too many tasks into community health worker 
activities can result in job stress and reduced eﬀ ectiveness 
of their work. To avoid work overload, HPV self-collection 
should be incorporated into community health worker 
activities after careful consideration of what they can 
realistically achieve in every speciﬁ c context, and after 
consideration of other competing responsibilities.17
In our study, only 1·3% of women who self-collected a 
sample were not tested for HPV, suggesting few logistical 
problems. Importantly, ﬁ ndings show that self-sampling 
can be oﬀ ered eﬀ ectively by male community health 
workers, because similar results were obtained for male 
and female community health workers. Thus, male 
community health workers were eﬀ ective in overcoming 
gender and subjective barriers—ie, embarrassment.
Screening programmes with high coverage will not 
result in a decrease in disease burden if women are not 
diagnosed and treated; therefore, self-collection must be 
implemented once diagnostic and treatment services are 
in place. In our study, 88% of self-collected HPV-positive 
women had colposcopy, and 85% of women with a 
histological diagnosis of CIN2+ were treated. This ﬁ gure 
is higher than that reported for Jujuy’s previous cytology-
based programme (70%)31 and is similar to that reported 
in a Chilean study,9 which indicates that although women 
who self-collected did not have initial contact with 
medical providers, and the average time between the test 
result and colposcopy was somewhat longer, the referral 
system worked adequately and community health 
workers were an eﬀ ective link between women and 
diagnostic services. Furthermore, a high level of colpos-
copic diagnoses was achieved despite referral of all self-
collected HPV-positive women. This approach might not 
be feasible in many middle-income settings, where 
availability of colposcopy is limited.32 Cytological or visual 
triage might be an option, but would need an additional 
visit to the health centre, thus reducing the advantage of 
self-collection. WHO guidelines include treating HPV-
positive women immediately with cryotherapy,33 and this 
procedure can be an option in settings with reduced 
diagnostic facilities.
Our trial was not designed to assess diﬀ erences in 
detection rates between methods (self-collection and 
clinician-collection). The proportion of CIN2+ disease 
detected by self-collection was 11% lower than that 
detected when clinicians collected samples, which is 
similar to data reported in a meta-analysis.7 Women with 
HPV-positive clinician-collected tests were referred for 
colposcopy when they had abnormal cytological ﬁ ndings, 
whereas those with self-collected tests were referred for 
colposcopy only if they were HPV-positive. However, in 
the intervention group, most colposcopists also did a Pap 
test before or together with colposcopy. Therefore, the 
proportion of detected CIN2+ disease that was reported 
for self-collection cannot be attributed to the original 
triage protocol. When data for cytology from this group 
were used to recalculate CIN2+ cases detected by 
cytological triage, as was done in the control group, at 
least twice as many lesions were still detected by self-
collection.
Despite the slightly lower proportion of CIN2+ cases 
detected after self-collection, the remarkable gain in 
screening uptake attributable to the intervention resulted 
in almost ﬁ ve times as many CIN2+ cases being detected. 
Self-collection has been recommended for salvage of 
screening under-users.7 In our study, self-collection was 
oﬀ ered to women irrespective of their attendance status, 
although 71% had no cervical screening registered in the 
previous 4 years. In many countries, gains in coverage 
Panel: Research in context
Systematic review
To deﬁ ne the study protocol, we searched PubMed between January, 2002, and 
December, 2012, with the key terms “cervical cancer”, “vaginal self-sampling”, “HPV 
testing”, “cervical cancer screening”, “clinical trials”, “self-collection”, “community health 
workers”, and “primary health care”; publications retrieved were reviewed for quality and 
relevance. We later extended the PubMed search to April, 2014, when writing the report. 
We only included studies written in English and Spanish. Much of the evidence about the 
eﬀ ect of HPV self-collection on screening uptake comes from developed countries, using 
postal systems,7,12,13 an approach that is not feasible in developing countries. We did not 
ﬁ nd any randomised study in which the eﬀ ectiveness of self-collection oﬀ ered by 
community health workers during home visits was evaluated in a programmatic setting.
Interpretation
In the EMA study, HPV self-collection oﬀ ered by community health workers at home 
visits was acceptable and highly eﬀ ective at increasing screening uptake. Even though 
self-collection led to a small reduction in the proportion of cases of CIN2+ disease 
detected, by comparison with clinician-collected tests, increased screening uptake 
allowed for the detection of a signiﬁ cantly larger number of cases of CIN2+ disease. HPV 
self-collection oﬀ ered by community health workers as a primary health care task reduces 
women’s barriers to screening and results in a substantial and rapid increase in coverage.
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could largely outweigh loss in self-collected test 
performance, particularly considering the enormous 
diﬃ  culties faced by most programmes to achieve good 
coverage rates. Thus, in settings where achieving high 
coverage is especially diﬃ  cult, self-collection might be 
regarded as an option for all women. Women’s preference 
should also be considered, and the potential personal 
gain from self-collection in terms of autonomy, privacy, 
time, and self-esteem.34 In our study, women were given 
the possibility to choose; most women accepted self-
collection, suggesting that women highly value the actual 
possibility of being tested with no delays. More evidence 
is needed about women’s preferences on this subject.
In our study, eligible women who did not take part in 
the study diﬀ ered from participants with respect to age 
distribution; non-participants might also have diﬀ ered in 
relation to other baseline variables and measured 
outcomes. This diversity might limit the generalisability 
of our results, although by a very small amount in view of 
the high proportion of eligible women who did participate 
(97%). Moreover, the community health workers selected 
were among the best-performing, recognising the need 
for a speciﬁ c level of motivation and skills. Inclusion of 
all community health workers would probably decrease 
eﬀ ectiveness of the strategy, which can be compensated 
for by training and close supervision. Thus, the cost and 
feasibility of including strong training and monitoring 
components have to be considered when evaluating self-
collection as a programmatic strategy.
The high eﬀ ect on screening coverage noted by our 
study was obtained by community health workers that are 
part of the Jujuy primary health-care system and, 
therefore, a question remains about how this experience 
can be replicated in other settings. Community health 
workers are active in many countries and oﬀ er a wide 
range of health services, from promotion of antenatal care 
and breastfeeding to preventive health education on 
malaria, tuberculosis, and sexually transmitted diseases.15–17 
In many settings, these workers have had a key role in the 
decline of health-related metrics such as maternal and 
child mortality.35 Therefore, incorporation of HPV self-
collection into the activities of community health workers 
could be feasible, as long as HPV testing is available and 
key components of a cervical cancer prevention 
programme are organised. In Jujuy, an information 
system and a diagnosis and treatment infrastructure 
existed already as part of the provincial programme.
HPV self-collection oﬀ ered by community health 
workers in a programmatic setting is highly eﬀ ective at 
increasing uptake of cervical screening, allowing for 
many more women to be detected with disease. Our 
study provides key evidence to delineate extension of 
HPV testing in Argentina, and for countries to increase 
screening coverage.
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